Stocks and Investing Stocks and Investing
Wed, November 9, 2022

Tazeen Ahmad Downgraded (ADCT) to Hold and Decreased Target to $7 on, Nov 9th, 2022


Published on 2024-10-28 00:01:56 - WOPRAI, Tazeen Ahmad
  Print publication without navigation
Tazeen Ahmad of B of A Securities, Downgraded "ADC Therapeutics SA" (ADCT) to Hold and Decreased Target from $14 to $7 on, Nov 9th, 2022.

Tazeen has made no other calls on ADCT in the last 4 months.



There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $11 on, Friday, September 9th, 2022


These are the ratings of the 2 analyists that currently disagree with Tazeen


  • Brian Cheng of "JP Morgan" Initiated at Buy and Held Target at $5 on, Wednesday, September 21st, 2022
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $21 on, Monday, September 19th, 2022
Contributing Sources